Skip to Main Content

Exclusive

Latest

Exclusive Bob Herman

STAT Plus: As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’

Exclusive Bob Herman

STAT Plus: UnitedHealth is on a buying spree of outpatient surgery centers

Exclusive Allison DeAngelis

STAT Plus: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships

Exclusive Lizzy Lawrence

STAT Plus: Medical device lobby says it’s tired of waiting on Medicare to cover breakthrough devices

Exclusive Brittany Trang

STAT Plus: Change Healthcare cyberattack outage could persist for weeks, UnitedHealth Group executive suggests

Exclusive Allison DeAngelis

STAT Plus: Biotech launches with $82 million for Parkinson’s cell therapy

Exclusive Ed Silverman

STAT Plus: White House to hold a listening session on reforming pharmacy benefit managers

Exclusive Angus Chen

MD Anderson tried — and failed — to resolve research credit dispute between two scientists, new documents show

All Coverage

Exclusive Sarah Owermohle

Key congressman blasts HHS for lack of cooperation on Covid-19

Exclusive Helen Branswell

STAT Plus: HHS leaves vacant more than half the slots on a key vaccine advisory panel

advertisement

Exclusive Megan Molteni

Texas Medicaid agrees to fully cover gene therapy for Afghan refugees’ infant

Exclusive Jonathan Wosen

STAT Plus: Ultima Genomics launching high-end DNA sequencers that can read genome for $100

Exclusive Rachel Cohrs

STAT Plus: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension

Exclusive Jason Mast

STAT Plus: Dewpoint Therapeutics cuts 15% of staff, acknowledges Merck, Pfizer broke off partnerships over buzzy science

Exclusive Megan Molteni

STAT Plus: The Afghan father aided U.S. soldiers. Now Texas Medicaid won’t pay for his son’s gene therapy

Exclusive Allison DeAngelis

STAT Plus: Former Sage executives join biotech VC Cure Ventures

Exclusive Casey Ross

STAT Plus: Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care

Exclusive Matthew Herper

STAT Plus: Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM

Exclusive Jason Mast

STAT Plus: Feng Zhang’s year-old CRISPR delivery startup Aera lays off quarter of staff

Exclusive Matthew Herper

STAT Plus: Amy Abernethy to step down as Verily’s chief medical officer in latest departure from company

Exclusive Matthew Herper

STAT Plus: Sanofi says it has 12 blockbusters in its back pocket. Will investors believe it?

Exclusive Lev Facher and Rachel Cohrs

STAT Plus: Sweeping bill to fight opioid addiction will be considered by Senate health committee

Exclusive Theresa Gaffney

The push to get estrogen FDA-approved for gender-affirming care

Exclusive Matthew Herper

STAT Plus: CRISPR’s pioneers reflect on the first gene-editing treatment

Exclusive Sarah Owermohle

STAT Plus: FDA’s latest reorganization puts a new emphasis on its investigations

A STAT Investigation Casey Ross and Bob Herman

STAT Plus: UnitedHealth pushed employees to follow an algorithm to cut off Medicare patients’ rehab care

Exclusive Mario Aguilar

STAT Plus: Apple and Anthem’s experimental asthma app shows early promise but its future is uncertain

Exclusive Olivia Goldhill

Cancun abortion clinic aims to serve Americans from restrictive states

Exclusive Bob Herman and Casey Ross

STAT Plus: UnitedHealth discontinues a controversial brand amid scrutiny of algorithmic care denials